Bamford A

References (1)

Title : Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease - Neumann_2021_BMC.Neurol_21_422

Author(s) : Neumann S , Taylor J , Bamford A , Metcalfe C , Gaunt DM , Whone A , Steeds D , Emmett SR , Hollingworth W , Ben-Shlomo Y , Henderson EJ

Ref : BMC Neurol , 21 :422 , 2021

Abstract :

PubMedSearch : Neumann_2021_BMC.Neurol_21_422

PubMedID: 34715821

Bamford A

References (1)

1. Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease - Neumann_2021_BMC.Neurol_21_422